Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pearson

Showing results (941-950 of 1,112) with videos related to

Pageof 112
Sort By:
Analytical Chemistry|July 21, 2017
Topological Dissection of the Membrane Transport Protein Mhp1 Derived from Cysteine Accessibility and Mass SpectrometryAntonio N Calabrese, Scott M Jackson, Lynsey N Jones, et al.
Chemistry & Biology|April 25, 2015
The structure of the PanD/PanZ protein complex reveals negative feedback regulation of pantothenate biosynthesis by coenzyme ADiana C F Monteiro, Vijay Patel, Christopher P Bartlett, et al.
Diabetes Care|October 14, 2025
Updating a Clinical Prediction Model for Identifying Monogenic Diabetes to Include Both Clinical Features and BiomarkersJulieanne Knupp, Pedro Cardoso, Katherine G Young, et al.
Multiple Sclerosis and Related Disorders|May 19, 2021
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapiesAfagh Garjani, Rodden M Middleton, Rachael Hunter, et al.
Lancet (London, England)|May 10, 2026
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trialEric F Morand, Maria Dall'Era, Jorge Sanchez-Guerrero, et al.
The Lancet. Primary Care|May 11, 2026
Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care dataThijs T Jansz, Andrew P McGovern, Katherine G Young, et al.
Cardiovascular Diabetology|March 27, 2025
BMI-residualized data uncovers a cluster of people with type 2 diabetes and increased serum ferritin protected from cardiovascular diseaseLaura Gallardo-Nuell, Jordi Blanch, Yenny Leal, et al.
Diabetologia|April 15, 2005
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collectionE R Pearson, S Pruhova, C J Tack, et al.
Alcoholism, Clinical and Experimental Research|August 8, 2020
Can Alcohol Use Disorder Recovery Include Some Heavy Drinking? A Replication and Extension up to 9 Years Following TreatmentKatie Witkiewitz, Matthew R Pearson, Adam D Wilson, et al.
American Heart Journal|October 31, 2006
Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary deathHeidi T May, Benjamin D Horne, Jeffrey L Anderson, et al.
Pageof 112

Showing results (941-950 of 1,112) with videos related to

Sort By:
Pageof 112
Analytical Chemistry|July 21, 2017
Topological Dissection of the Membrane Transport Protein Mhp1 Derived from Cysteine Accessibility and Mass SpectrometryAntonio N Calabrese, Scott M Jackson, Lynsey N Jones, et al.
Chemistry & Biology|April 25, 2015
The structure of the PanD/PanZ protein complex reveals negative feedback regulation of pantothenate biosynthesis by coenzyme ADiana C F Monteiro, Vijay Patel, Christopher P Bartlett, et al.
Diabetes Care|October 14, 2025
Updating a Clinical Prediction Model for Identifying Monogenic Diabetes to Include Both Clinical Features and BiomarkersJulieanne Knupp, Pedro Cardoso, Katherine G Young, et al.
Multiple Sclerosis and Related Disorders|May 19, 2021
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapiesAfagh Garjani, Rodden M Middleton, Rachael Hunter, et al.
Lancet (London, England)|May 10, 2026
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trialEric F Morand, Maria Dall'Era, Jorge Sanchez-Guerrero, et al.
The Lancet. Primary Care|May 11, 2026
Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care dataThijs T Jansz, Andrew P McGovern, Katherine G Young, et al.
Cardiovascular Diabetology|March 27, 2025
BMI-residualized data uncovers a cluster of people with type 2 diabetes and increased serum ferritin protected from cardiovascular diseaseLaura Gallardo-Nuell, Jordi Blanch, Yenny Leal, et al.
Diabetologia|April 15, 2005
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collectionE R Pearson, S Pruhova, C J Tack, et al.
Alcoholism, Clinical and Experimental Research|August 8, 2020
Can Alcohol Use Disorder Recovery Include Some Heavy Drinking? A Replication and Extension up to 9 Years Following TreatmentKatie Witkiewitz, Matthew R Pearson, Adam D Wilson, et al.
American Heart Journal|October 31, 2006
Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary deathHeidi T May, Benjamin D Horne, Jeffrey L Anderson, et al.
Pageof 112